ESPR logo

Esperion Therapeutics, Inc. (ESPR)

Profile

Full Name

Esperion Therapeutics, Inc.

Ticker

NASDAQ: ESPR

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

June 26, 2013

Indexes

Not included

Website

https://www.esperion.com

Employees

304

Key Details

Price

$2.22(+0.45%)

Market cap

$447.60M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$332.31M(+185.66% YoY)

Annual EPS

-$0.28(+86.21% YoY)

PE ratio

-

Next earnings date

Nov 4, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.22
    ESPR price is $2.22

    30-Day Relative Volume

    1.36
    ESPR 30-day relative volume is 1.36

    Price Performance

    Price Most recent change

    +0.45%
    ESPR price was up +0.45% on Aug 29, 2025

    Price YTD change

    +0.91%
    ESPR price is up +0.91% since January 1st

    Price 1-year change

    +26.86%
    ESPR price is up +26.86% year-on-year

    Price 3-year change

    -70.4%
    ESPR price is down -70.4% over the past 3 years

    Price Range

    Price All-time high

    $120.96
    ESPR price is currently -98.16% below its historical high of $120.96

    Price 3-year low

    $0.69
    ESPR price is currently +221.74% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $447.60M
    ESPR market capitalization is $447.60 million

    Market cap 3-year change

    -10.32%
    ESPR market capitalization is down -10.32% over the past 3 years

    Market cap All-time high

    $2.59B
    ESPR market capitalization is currently -82.72% below its historical high of $2.59 billion

    Market cap sector rank

    63.35%
    ESPR market capitalization is higher than 63.35% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.75%
    ESPR shares outstanding is up +2.75% year-on-year

    Shares Outstanding 3-Year Change

    +202.96%
    ESPR shares outstanding is up +202.96% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.24
    ESPR beta is 1.24

    200-day SMA

    $1.66
    ESPR price is currently +33.98% above its 200-day simple moving average

    50-day SMA

    $1.52
    ESPR price is currently +45.82% above its 50-day simple moving average

    RSI

    73.41
    ESPR 14-day relative strength index is 73.41

    Volume

    1.36
    ESPR 30-day relative volume is 1.36

    ATR

    $0.14
    ESPR average true range is $0.14

    10-day Historical Volatility

    30.44%
    ESPR 10-day historical volatility is 30.44%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $332.31M
    ESPR annual revenue is $332.31 million

    Revenue Analysts estimate

    $367.20M
    ESPR annual revenue is currently -9.50% lower than the consensus analysts' forecast

    Revenue 1-year change

    +185.66%
    ESPR annual revenue is up +185.66% year-on-year

    Revenue Sector rank

    78.19%
    ESPR annual revenue is higher than 78.19% of companies in Healthcare sector

    EPS

    EPS

    -$0.28
    ESPR annual earnings per share is -$0.28

    EPS Analysts estimate

    -$0.02
    ESPR annual earnings per share is currently +1576.65% higher than the consensus analysts' forecast

    EPS 1-year change

    +86.21%
    ESPR annual earnings per share is up +86.21% year-on-year

    EPS Sector rank

    69.1%
    ESPR annual earnings per share is higher than 69.1% of companies in Healthcare sector

    Profit

    Gross profit

    $263.71M
    ESPR annual gross profit is $263.71 million

    Gross margin

    79.36%
    ESPR annual gross profit margin is 79.36%

    Operating profit

    $54.40M
    ESPR annual operating income is $54.40 million

    Operating margin

    16.37%
    ESPR annual operating profit margin is 16.37%

    Net income

    -$51.74M
    ESPR annual net profit is -$51.74 million

    Net margin

    -15.57%
    ESPR annual net profit margin is -15.57%

    Expenses

    Total expenses

    $277.91M
    ESPR annual total expenses is $277.91 million

    Operating expenses

    $209.31M
    ESPR annual total operating expenses is $209.31 million

    Cost of goods sold

    $68.60M
    ESPR annual cost of goods sold is $68.60 million

    Selling, general & administrative expenses

    $163.07M
    ESPR annual SGA is $163.07 million

    Depreciation and amortization

    $63.00K
    ESPR annual depreciation & amortization is $63.00 thousand

    Interest expense

    $0.00
    ESPR annual interest expense is $0.00

    Income tax

    $0.00
    ESPR annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    $7.51M
    ESPR annual earnings before interest & taxes is $7.51 million

    EBITDA

    $7.51M
    ESPR annual EBITDA is $7.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $345.34M
    ESPR annual total assets is $345.34 million

    Non current assets

    $5.82M
    ESPR annual long term assets is $5.82 million

    Current assets

    $144.76M
    ESPR annual total current assets is $144.76 million

    Cash and cash equivalents

    $144.76M
    ESPR annual cash & cash equivalents is $144.76 million

    Accounts receivable

    $80.14M
    ESPR annual accounts receivable is $80.14 million

    Inventory

    $94.49M
    ESPR annual inventory is $94.49 million

    Liabilities

    Total liabilities

    $734.06M
    ESPR annual total liabilities is $734.06 million

    Long term liabilities

    $486.31M
    ESPR annual total long term liabilities is $486.31 million

    Current liabilities

    $246.23M
    ESPR annual total current liabilities is $246.23 million

    Accounts payable

    $51.65M
    ESPR annual accounts payable is $51.65 million

    Debt

    Total debt

    $591.21M
    ESPR annual total debt is $591.21 million

    Total debt 1-year change

    +9.29%
    ESPR annual total debt is up +9.29% year-on-year

    Long term debt

    $486.31M
    ESPR annual long term debt is $486.31 million

    Short term debt

    $104.90M
    ESPR annual short term debt is $104.90 million

    Equity & Capital

    Shareholders equity

    -$388.72M
    ESPR annual stockholders equity is -$388.72 million

    Book value

    -$1.60B
    ESPR annual book value is -$1.60 billion

    Retained earnings

    -$1.60B
    ESPR annual retained earnings is -$1.60 billion

    Working capital

    $91.77M
    ESPR annual working capital is $91.77 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$23.65M
    ESPR annual cash flow from operations is -$23.65 million

    Cash from operations 1-year change

    +82.54%
    ESPR annual cash flow from operations is up +82.54% year-on-year

    Cash from investing

    -$317.00K
    ESPR annual cash flow from investing activities is -$317.00 thousand

    Cash from investing 1-year change

    -100.75%
    ESPR annual cash flow from investing activities is down -100.75% year-on-year

    Cash from financing

    $86.48M
    ESPR annual cash flow from financing activities is $86.48 million

    Cash from financing 1-year change

    +71.39%
    ESPR annual cash flow from financing activities is up +71.39% year-on-year

    CAPEX

    CAPEX

    $317.00K
    ESPR annual capital expenditures is $317.00 thousand

    CAPEX 1-year change

    +100%
    ESPR annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free cash flow

    -$23.97M
    ESPR annual free cash flow is -$23.97 million

    Free cash flow 1-year change

    +82.31%
    ESPR annual free cash flow is up +82.31% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    79.36%
    ESPR annual gross profit margin is 79.36%

    Operating margin

    16.37%
    ESPR annual operating profit margin is 16.37%

    Net margin

    -15.57%
    ESPR annual net profit margin is -15.57%

    ROA & ROE

    ROA

    -18.78%
    ESPR annual return on assets is -18.78%

    ROE

    13.31%
    ESPR annual return on equity is 13.31%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ESPR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ESPR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -1.03
    ESPR price to book ratio is -1.03

    PB ratio Sector rank

    10.56%
    ESPR price to book ratio is higher than 10.56% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.67
    ESPR price to sales ratio is 1.67

    PS ratio Sector rank

    31.66%
    ESPR price to sales ratio is higher than 31.66% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $959.72M
    ESPR enterprise value is $959.72 million

    Enterprise value Sector rank

    74.06%
    ESPR enterprise value is higher than 74.06% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -39.03
    ESPR EV/EBITDA is -39.03

    EV/EBITDA Sector rank

    3.45%
    ESPR EV/EBITDA is higher than 3.45% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.37
    ESPR annual current ratio is 1.37

    Quick ratio

    0.20
    ESPR annual quick ratio is 0.20

    Leverage

    Debt to equity

    0.00
    ESPR annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ESPR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    1
    ESPR piotroski f-score is 1

    Altman Z-Score

    -4.77
    ESPR altman z-score is -4.77

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 HC Wainwright & Co.
    Buy
    May 7, 25 Needham
    Buy
    Apr 25, 25 Needham
    Buy
    Apr 25, 25 HC Wainwright & Co.
    Buy
    Apr 17, 25 Goldman Sachs
    Neutral
    Apr 8, 25 Needham
    Buy
    Mar 20, 25 HC Wainwright & Co.
    Buy
    Mar 5, 25 Citizens Capital Markets
    Market Outperform
    Mar 4, 25 HC Wainwright & Co.
    Buy
    Feb 11, 25 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with ESPR included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Stocks ready to break out
    Healthcare sector
    • What is the ticker symbol for Esperion Therapeutics, Inc.?
    • Does Esperion Therapeutics, Inc. pay dividends?
    • What sector is Esperion Therapeutics, Inc. in?
    • What industry is Esperion Therapeutics, Inc. in?
    • What country is Esperion Therapeutics, Inc. based in?
    • When did Esperion Therapeutics, Inc. go public?
    • Is Esperion Therapeutics, Inc. in the S&P 500?
    • Is Esperion Therapeutics, Inc. in the NASDAQ 100?
    • Is Esperion Therapeutics, Inc. in the Dow Jones?
    • When was Esperion Therapeutics, Inc.'s last earnings report?
    • When does Esperion Therapeutics, Inc. report earnings?

    What is the ticker symbol for Esperion Therapeutics, Inc.?

    The ticker symbol for Esperion Therapeutics, Inc. is NASDAQ:ESPR

    Does Esperion Therapeutics, Inc. pay dividends?

    No, Esperion Therapeutics, Inc. does not pay dividends

    What sector is Esperion Therapeutics, Inc. in?

    Esperion Therapeutics, Inc. is in the Healthcare sector

    What industry is Esperion Therapeutics, Inc. in?

    Esperion Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Esperion Therapeutics, Inc. based in?

    Esperion Therapeutics, Inc. is headquartered in United States

    When did Esperion Therapeutics, Inc. go public?

    Esperion Therapeutics, Inc.'s initial public offering (IPO) was on June 26, 2013

    Is Esperion Therapeutics, Inc. in the S&P 500?

    No, Esperion Therapeutics, Inc. is not included in the S&P 500 index

    Is Esperion Therapeutics, Inc. in the NASDAQ 100?

    No, Esperion Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Esperion Therapeutics, Inc. in the Dow Jones?

    No, Esperion Therapeutics, Inc. is not included in the Dow Jones index

    When was Esperion Therapeutics, Inc.'s last earnings report?

    Esperion Therapeutics, Inc.'s most recent earnings report was on August 5, 2025

    When does Esperion Therapeutics, Inc. report earnings?

    The next expected earnings date for Esperion Therapeutics, Inc. is November 4, 2025
    On this page